336 related articles for article (PubMed ID: 38673487)
1. Optic Nerve Neuroprotection in Glaucoma: A Narrative Review.
D'Angelo A; Vitiello L; Lixi F; Abbinante G; Coppola A; Gagliardi V; Pellegrino A; Giannaccare G
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673487
[TBL] [Abstract][Full Text] [Related]
2. Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects.
Boccaccini A; Cavaterra D; Carnevale C; Tanga L; Marini S; Bocedi A; Lacal PM; Manni G; Graziani G; Sbardella D; Tundo GR
Mol Aspects Med; 2023 Dec; 94():101225. PubMed ID: 38000334
[TBL] [Abstract][Full Text] [Related]
3. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
4. Cytidine 5'-Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma.
Gandolfi S; Marchini G; Caporossi A; Scuderi G; Tomasso L; Brunoro A
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32197303
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection for treatment of glaucoma in adults.
Sena DF; Lindsley K
Cochrane Database Syst Rev; 2013 Feb; 2(2):CD006539. PubMed ID: 23450569
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection for treatment of glaucoma in adults.
Sena DF; Lindsley K
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
Almasieh M; Levin LA
Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of neuroprotection in glaucoma.
Wein FB; Levin LA
Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser
Means JC; Lopez AA; Koulen P
Cell Mol Neurobiol; 2020 Aug; 40(6):911-926. PubMed ID: 31919747
[TBL] [Abstract][Full Text] [Related]
10. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy Strategies for Glaucomatous Neurodegeneration.
Lani-Louzada R; Dias MS; Linden R; Ribas VT; Petrs-Silva H
Curr Gene Ther; 2021; 21(5):362-381. PubMed ID: 33573569
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies.
Marcic TS; Belyea DA; Katz B
Curr Opin Ophthalmol; 2003 Dec; 14(6):353-6. PubMed ID: 14615639
[TBL] [Abstract][Full Text] [Related]
13. Probing mechanisms and improving management of glaucoma following Boston keratoprosthesis surgery.
Geoffrion D; Koenekoop RK; Harissi-Dagher M
Acta Ophthalmol; 2022 Dec; 100 Suppl 274():3-17. PubMed ID: 36482042
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection for treatment of glaucoma in adults.
Sena DF; Ramchand K; Lindsley K
Cochrane Database Syst Rev; 2010 Feb; (2):CD006539. PubMed ID: 20166085
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection in glaucoma--delusion, reality or hope?
Dimovska-Jordanova A
Prilozi; 2012; 33(2):163-73. PubMed ID: 23425879
[TBL] [Abstract][Full Text] [Related]
16. Translational Pharmacology in Glaucoma Neuroprotection.
Levin LA
Handb Exp Pharmacol; 2017; 242():209-230. PubMed ID: 27752844
[TBL] [Abstract][Full Text] [Related]
17. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
Yamamoto T
Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction.
Tribble JR; Otmani A; Sun S; Ellis SA; Cimaglia G; Vohra R; Jöe M; Lardner E; Venkataraman AP; Domínguez-Vicent A; Kokkali E; Rho S; Jóhannesson G; Burgess RW; Fuerst PG; Brautaset R; Kolko M; Morgan JE; Crowston JG; Votruba M; Williams PA
Redox Biol; 2021 Jul; 43():101988. PubMed ID: 33932867
[TBL] [Abstract][Full Text] [Related]
19. Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art.
Lambuk L; Mohd Lazaldin MA; Ahmad S; Iezhitsa I; Agarwal R; Uskoković V; Mohamud R
Front Pharmacol; 2022; 13():875662. PubMed ID: 35668928
[TBL] [Abstract][Full Text] [Related]
20. Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma.
Martucci A; Nucci C
Neural Regen Res; 2019 Feb; 14(2):197-200. PubMed ID: 30530997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
